Genmab A/S (GMAB) Reports FY EPS of $15.37

Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.

For earnings history and earnings-related data on Genmab A/S (GMAB) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• SpaceX (SPCX) gains nearly 6% as traders follow the money
• Nexgen Energy sharing technical information with BHP as Nexgen looks to raise over $ 1 billion for Rook I mine - Reuters